Dwight Moxie - 27 Sep 2021 Form 4 Insider Report for Revance Therapeutics, Inc.

Role
SVP, GC & Secretary
Signature
/s/ Dwight Moxie, SVP, GC & Secretary
Issuer symbol
N/A
Transactions as of
27 Sep 2021
Net transactions value
-$50,250
Form type
4
Filing time
28 Sep 2021, 21:23:41 UTC
Next filing
04 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Sale $50,250 -1,675 -3.4% $30.00 47,804 27 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Moxie.